Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Yu Xia

Director at Summit Therapeutics Inc. (SMMT)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-10.1%
vs. S&P 500-12.5%
Beat the market0%
Paper profit on buys−$614K
Total bought / sold$10.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 23SEC SMMTSummit Therapeutics Inc. Buy 533,61732,057,147 held (+2%) $18.74 $10.0M -6.1%
  • Buy

    Director Yu Xia bought $10.0M of SMMT at $18.74 — first open-market purchase in our records.